Elsevier

Journal of Infection

Volume 86, Issue 2, February 2023, Pages 154-225
Journal of Infection

Letter to the Editor
No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis

https://doi.org/10.1016/j.jinf.2022.11.022Get rights and content

Highlights

  • •

    We assessed the effect of famotidine administration in COVID-19 patients.

  • •

    We included 10 studies out of which 3 were randomized controlled trials (RCTs).

  • •

    Famotidine does not reduce mortality or hasten recovery in COVID-19 patients.

  • •

    Large-scale RCTs are needed to investigate its efficacy.

Keywords

Famotidine
COVID-19
SARS-CoV-2
Histamine H2-receptor antagonists

Cited by (0)

View Abstract
© 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.